ACROBiosystems Hits Day Low of CNY 85 Amid Price Pressure

ACROBiosystems Co., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 4.02% on August 26, 2026, reaching an intraday low of CNY 85.00. This performance contrasts sharply with the China Shanghai Composite, which recorded a modest gain of 0.59% on the same day. Despite the recent downturn, ACROBiosystems has shown resilience over the past week, with a 2.97% increase, and impressive growth over the past month at 69.09%. Year-to-date, the stock has risen by 63.52%, significantly outperforming the broader market, which has seen a decline of 1.42%. Financial metrics indicate a mixed performance for ACROBiosystems. The company reported a return on equity of 6.17% and a price-to-book ratio of 4.50, suggesting a fair valuation. However, the stock has underperformed over the past year, generating negative returns of 32.82%, while profits increased by 27.1%. The company's market capitalization stands at CNY 12,145 million, reflecting its large-cap status within the industry.